Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the primary study hypotheses related to the combination of lenvatinib + platinum doublet chemotherapy + pembrolizumab in adults with metastatic nonsquamous non-small cell lung cancer, focusing on the prolongation of Progression-free Survival (PFS) and Overall Survival (OS) compared to matching placebo + platinum doublet chemotherapy + pembrolizumab.
    Difference
    0.0%
    Check dated 2024-06-06T14:53:54.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a more detailed description, now labeled as 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which includes examples such as a person's general health condition or prior treatments. This change provides a clearer explanation of the criteria used to determine eligibility for clinical research studies.
    Difference
    30%
    Check dated 2024-05-22T21:37:10.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:17:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.